News for Antares Pharma, Inc. (ATRS)

PR NewswireSAN DIEGO, Feb. 18, 2025 Fourth Quarter Total Revenue Increased 30% YOY to $298 million and Royalty Revenue Increased 40% YOY to $170 millionFou

Ms. Colacot brings over 25 years of quality leadership experience across the biopharmaceutical and medical device industries NEW YORK, Jan. 21, 2025 (GLOBE

Halozyme's Q3 earnings exceeded expectations, with a $1.27 EPS and 34% YoY revenue growth, driven by ENHANZE tech and strong partnerships with J&J and Roche. Read more here.

HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS

The Needle-Free Injector Market is growing rapidly along with the escalating requirements of pain-free drug delivery systems, greater needle-phobic...

Context Therapeutics enhances board with new appointments

Seasoned industry veteran adds significant global biotech and biopharma experience to Skye’s Board of Directors...

Reiterating 2024 Financial Guidance: Total Revenue of $915-985 Million, Representing YOY Growth of 10-19%, Adjusted EBITDA of $535-585 Million, Representing YOY Growth of 26- 37% and Non-GAAP...

Kazia Therapeutics strengthens board with new appointments

Leading drug delivery devices market players include Antares Pharma, Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis International AG,...

/PRNewswire/ -- The "Global Epinephrine Autoinjector Market (2023-2028) by Dosage, Application, End User, and Geography, Competitive Analysis, Impact of...

Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.

/PRNewswire/ -- The

/PRNewswire/ -- The global immunology market size is estimated to grow by USD 56.07 billion from 2022 to 2027, according to Technavio. The market is estimated...

Acumen Research and Consulting recently published report titled “Needle-Free Injection Market and Region Forecast, 2022 - 2030”...

The global drug delivery devices market is anticipated to grow positively due to the rising number of diabetes patients, the rising prevalence of cancer...

The Global Remote Patient Monitoring Market was worth USD 1.3 billion in 2020 and, with a CAGR of 12.1%, is expected to reach a market value of USD 4.07...

In 2020, the market was worth USD 6.15 billion and, with a CAGR of 5.71%, is expected to reach a market value of USD 10.71 billion by 2030 according to...

Read Research Analysts’ New Coverage for June 19th (AAMC, AAU, ACY, AMPE, ATRS, EPAY, IIN, JOBS, LPTH, MBRX) at ETF Daily News